242 related articles for article (PubMed ID: 11279005)
1. The specificity of receptor binding by vascular endothelial growth factor-d is different in mouse and man.
Baldwin ME; Catimel B; Nice EC; Roufail S; Hall NE; Stenvers KL; Karkkainen MJ; Alitalo K; Stacker SA; Achen MG
J Biol Chem; 2001 Jun; 276(22):19166-71. PubMed ID: 11279005
[TBL] [Abstract][Full Text] [Related]
2. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development.
Kukk E; Lymboussaki A; Taira S; Kaipainen A; Jeltsch M; Joukov V; Alitalo K
Development; 1996 Dec; 122(12):3829-37. PubMed ID: 9012504
[TBL] [Abstract][Full Text] [Related]
3. A mutant form of vascular endothelial growth factor (VEGF) that lacks VEGF receptor-2 activation retains the ability to induce vascular permeability.
Stacker SA; Vitali A; Caesar C; Domagala T; Groenen LC; Nice E; Achen MG; Wilks AF
J Biol Chem; 1999 Dec; 274(49):34884-92. PubMed ID: 10574962
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3.
Achen MG; Roufail S; Domagala T; Catimel B; Nice EC; Geleick DM; Murphy R; Scott AM; Caesar C; Makinen T; Alitalo K; Stacker SA
Eur J Biochem; 2000 May; 267(9):2505-15. PubMed ID: 10785369
[TBL] [Abstract][Full Text] [Related]
5. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
Joukov V; Pajusola K; Kaipainen A; Chilov D; Lahtinen I; Kukk E; Saksela O; Kalkkinen N; Alitalo K
EMBO J; 1996 Jan; 15(2):290-98. PubMed ID: 8617204
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium.
Paavonen K; Mandelin J; Partanen T; Jussila L; Li TF; Ristimaki A; Alitalo K; Konttinen YT
J Rheumatol; 2002 Jan; 29(1):39-45. PubMed ID: 11824969
[TBL] [Abstract][Full Text] [Related]
7. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice.
Veikkola T; Jussila L; Makinen T; Karpanen T; Jeltsch M; Petrova TV; Kubo H; Thurston G; McDonald DM; Achen MG; Stacker SA; Alitalo K
EMBO J; 2001 Mar; 20(6):1223-31. PubMed ID: 11250889
[TBL] [Abstract][Full Text] [Related]
8. Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2.
Kirkin V; Mazitschek R; Krishnan J; Steffen A; Waltenberger J; Pepper MS; Giannis A; Sleeman JP
Eur J Biochem; 2001 Nov; 268(21):5530-40. PubMed ID: 11683876
[TBL] [Abstract][Full Text] [Related]
9. Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers.
Stacker SA; Stenvers K; Caesar C; Vitali A; Domagala T; Nice E; Roufail S; Simpson RJ; Moritz R; Karpanen T; Alitalo K; Achen MG
J Biol Chem; 1999 Nov; 274(45):32127-36. PubMed ID: 10542248
[TBL] [Abstract][Full Text] [Related]
10. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.
He Y; Kozaki K; Karpanen T; Koshikawa K; Yla-Herttuala S; Takahashi T; Alitalo K
J Natl Cancer Inst; 2002 Jun; 94(11):819-25. PubMed ID: 12048269
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4).
Achen MG; Jeltsch M; Kukk E; Mäkinen T; Vitali A; Wilks AF; Alitalo K; Stacker SA
Proc Natl Acad Sci U S A; 1998 Jan; 95(2):548-53. PubMed ID: 9435229
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes.
Gilbert RE; Vranes D; Berka JL; Kelly DJ; Cox A; Wu LL; Stacker SA; Cooper ME
Lab Invest; 1998 Aug; 78(8):1017-27. PubMed ID: 9714188
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1.
Wise LM; Veikkola T; Mercer AA; Savory LJ; Fleming SB; Caesar C; Vitali A; Makinen T; Alitalo K; Stacker SA
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3071-6. PubMed ID: 10077638
[TBL] [Abstract][Full Text] [Related]
14. Expression of VEGF-C and activation of its receptors VEGFR-2 and VEGFR-3 in trophoblast.
Dunk C; Ahmed A
Histol Histopathol; 2001 Apr; 16(2):359-75. PubMed ID: 11332691
[TBL] [Abstract][Full Text] [Related]
15. Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer.
Yonemura Y; Fushida S; Bando E; Kinoshita K; Miwa K; Endo Y; Sugiyama K; Partanen T; Yamamoto H; Sasaki T
Eur J Cancer; 2001 May; 37(7):918-23. PubMed ID: 11313181
[TBL] [Abstract][Full Text] [Related]
16. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3.
Mäkinen T; Veikkola T; Mustjoki S; Karpanen T; Catimel B; Nice EC; Wise L; Mercer A; Kowalski H; Kerjaschki D; Stacker SA; Achen MG; Alitalo K
EMBO J; 2001 Sep; 20(17):4762-73. PubMed ID: 11532940
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor (VEGF) and VEGF-C show overlapping binding sites in embryonic endothelia and distinct sites in differentiated adult endothelia.
Lymboussaki A; Olofsson B; Eriksson U; Alitalo K
Circ Res; 1999 Nov; 85(11):992-9. PubMed ID: 10571529
[TBL] [Abstract][Full Text] [Related]
18. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG
J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824
[TBL] [Abstract][Full Text] [Related]
19. Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin.
Enholm B; Karpanen T; Jeltsch M; Kubo H; Stenback F; Prevo R; Jackson DG; Yla-Herttuala S; Alitalo K
Circ Res; 2001 Mar; 88(6):623-9. PubMed ID: 11282897
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor (VEGF) receptor II-derived peptides inhibit VEGF.
Piossek C; Schneider-Mergener J; Schirner M; Vakalopoulou E; Germeroth L; Thierauch KH
J Biol Chem; 1999 Feb; 274(9):5612-9. PubMed ID: 10026178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
